John McCabe resigned as CFO of Eleven Biotherapeutics Inc., effective Oct. 20.

McCabe did not resign due to any disagreements relating to the company's operations, policies or practices or any other company officer or director.

Eleven Biotherapeutics appointed Richard Fitzgerald as interim CFO, effective Oct. 13.

Fitzgerald most recently served as a consultant to private life science based companies from July through October. Previously, Fitzgerald served as CFO of medical device maker PAVmed Inc. from October 2015 through March 2017.